Search Results - "O'SHAUGHNESSY, M. V"

Refine Results
  1. 1

    Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy by Hogg, Robert S, Heath, Katherine V, Yip, Benita, Craib, Kevin J. P, O'Shaughnessy, Michael V, Schechter, Martin T, Montaner, Julio S. G

    “…CONTEXT.— Clinical trials have established the efficacy of antiretroviral therapy with double- and triple-drug regimens for individuals infected with the human…”
    Get full text
    Journal Article
  2. 2

    Hospital utilization and costs in a cohort of injection drug users by Palepu, A, Tyndall, M W, Leon, H, Muller, J, O'Shaughnessy, M V, Schechter, M T, Anis, A H

    “…Many injection drug users (IDUs) seek care at emergency departments and some require hospital admission because of late presentation in the course of their…”
    Get full text
    Journal Article
  3. 3

    Barriers to Use of Free Antiretroviral Therapy in Injection Drug Users by Strathdee, Steffanie A, Palepu, Anita, Cornelisse, Peter G. A, Yip, Benita, O'Shaughnessy, Michael V, Montaner, Julio S. G, Schechter, Martin T, Hogg, Robert S

    “…CONTEXT.— In British Columbia, human immunodeficiency virus (HIV)–infected persons eligible for antiretroviral therapy may receive it free but the extent to…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database by HEATH, Katherine V, HOGG, Robert S, CHAN, Keith J, HARRIS, Marianne, MONTESSORI, Valerie, O'SHAUGHNESSY, Michael V, MONTANER, Julio S. G

    Published in AIDS (London) (26-01-2001)
    “…To provide population-based estimates of the prevalence of lipodystrophy syndrome and constituent symptoms and to identify correlates of prevalent…”
    Get full text
    Journal Article
  6. 6

    Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: Outcomes from a population-based cohort by Braitstein, P., Montessori, V., Chan, K., Montaner, J. S. G., Schechter, M. T., O'Shaughnessy, M. V., Hogg, R. S.

    Published in AIDS care (01-05-2005)
    “…The objective of the study was to describe the additional burden generated by hepatitis C (HCV) infection among HIV-infected individuals as measured by…”
    Get full text
    Journal Article
  7. 7

    Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? by Wood, E, Tyndall, M W, Spittal, P M, Li, K, Kerr, T, Hogg, R S, Montaner, J S, O'Shaughnessy, M V, Schechter, M T

    “…In several European countries safer injecting rooms have reduced the public disorder and health-related problems of injection drug use. We explored factors…”
    Get full text
    Journal Article
  8. 8

    Surviving the sex trade: A comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs by Spittal, P. M., Bruneau, J., Craib, K. J. P., Miller, C., Lamothe, F., Weber, A. E., Li, K., Tyndall, M.W., O'Shaughnessy, M. V., Schechter, M. T.

    Published in AIDS care (01-04-2003)
    “…In Canada, very little is known about the factors and processes that cause drug-related harm among female intravenous drug users (IDUs). Women who inject drugs…”
    Get full text
    Journal Article
  9. 9

    Needle exchange is not enough : lessons from the Vancouver injecting drug use study by STRATHDEE, S. A, PATRICK, D. M, CURRIE, S. L, CORNELISSE, P. G. A, REKART, M. L, MONTANER, J. S. G, SCHECHTER, M. T, O'SHAUGHNESSY, M. V

    Published in AIDS (London) (01-07-1997)
    “…To describe prevalence and incidence of HIV-1, hepatitis C virus (HCV) and risk behaviours in a prospective cohort of injecting drugs users (IDU). Vancouver,…”
    Get full text
    Journal Article
  10. 10

    Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens by Hogg, R S, Yip, B, Kully, C, Craib, K J, O'Shaughnessy, M V, Schechter, M T, Montaner, J S

    “…The efficacy of triple-drug antiretroviral regimens in the treatment of patients infected with HIV has been established in several randomized clinical trials…”
    Get full text
    Journal Article
  11. 11

    Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection by Patrick, D M, Tyndall, M W, Cornelisse, P G, Li, K, Sherlock, C H, Rekart, M L, Strathdee, S A, Currie, S L, Schechter, M T, O'Shaughnessy, M V

    “…Beginning in 1994, Vancouver experienced an explosive outbreak of HIV infection among injection drug users (IDUs). The objectives of this study were to measure…”
    Get full text
    Journal Article
  12. 12

    Sources and Magnitude of Intralaboratory Variability in a Sequence-Based Genotypic Assay for Human Immunodeficiency Virus Type 1 Drug Resistance by GALLI, R. A, SATTHA, B, WYNHOVEN, B, O'SHAUGHNESSY, M. V, HARRIGAN, P. R

    Published in Journal of Clinical Microbiology (01-07-2003)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Do needle exchange programmes increase the spread of HIV among injection drug users? : an investigation of the Vancouver outbreak by SCHECHTER, M. T, STRATHDEE, S. A, CORNELISSE, P. G. A, CURRIE, S, PATRICK, D. M, REKART, M. L, O'SHAUGHNESSY, M. V

    Published in AIDS (London) (16-04-1999)
    “…An association between needle exchange attendance and higher HIV prevalence rates among injecting drug users (IDU) in Vancouver has been interpreted by some to…”
    Get full text
    Journal Article
  15. 15

    Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control by Tyndall, M W, Patrick, D, Spittal, P, Li, K, O'Shaughnessy, M V, Schechter, M T

    Published in Sexually transmitted infections (01-04-2002)
    “…Injection drug use is inextricably linked to commercial sex work and the transmission of sexually transmitted disease (STD). In many communities prevention…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Health Related Quality of Life among Persons with HIV after the Use of Protease Inhibitors by S. Low-Beer, Chan, K., Wood, E., B. Yip, J. S. G. Montaner, M. V. O'Shaughnessy, R. S. Hogg

    Published in Quality of life research (01-01-2000)
    “…Objective: This study was conducted to determine the effect of the use of HIV protease inhibitors on the quality of life among persons infected with HIV…”
    Get full text
    Journal Article
  18. 18

    Depressive symptoms decline among persons on HIV protease inhibitors by LOW-BEER, S, CHAN, K, YIP, B, WOOD, E, MONTANER, J. S. G, O'SHAUGHNESSY, M. V, HOGG, R. S

    “…To ascertain whether initiation of protease inhibitors was associated with a change in depressive symptoms among persons infected with HIV. Study subjects…”
    Get full text
    Journal Article
  19. 19

    Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada by STRATHDEE, S. A, PATRICK, D. M, ARCHIBALD, C. P, OFNER, M, CORNELISSE, P. G. A, REKART, M, SCHECHTER, M. T, O'SHAUGHNESSY, M. V

    Published in Addiction (Abingdon, England) (01-10-1997)
    “…Despite the fact that needle exchange was introduced in Vancouver as early as 1988, needle sharing remains common. An analysis was conducted to identify…”
    Get full text
    Journal Article
  20. 20

    Variation in Plasma RNA Levels, CD4 Cell Counts, and p24 Antigen Levels in Clinically Stable Men with Human Immunodeficiency Virus Infection by Raboud, J. M., Montaner, J. S. G., Conway, B., Haley, L., Sherlock, C., O'Shaughnessy, M. V., Schechter, M. T.

    Published in The Journal of infectious diseases (01-07-1996)
    “…Short-term variability in CD4 cell counts, plasma RNA levels, and p24 antigenemia was measured in clinically stable men with human immunodeficiency virus…”
    Get full text
    Journal Article